Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism.

[1]  N. Topley,et al.  Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. , 1994, Kidney international. Supplement.

[2]  D. Zemel,et al.  Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. , 1994, Kidney international.

[3]  E. Stylianou,et al.  Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines. , 1994, Kidney international.

[4]  J. Cameron,et al.  Immunohistochemical studies of the peritoneal membrane and infiltrating cells in normal subjects and in patients on CAPD. , 1994, Kidney international.

[5]  C. Visser,et al.  Analysis of the peritoneal cellular immune system during CAPD shortly before a clinical peritonitis. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  M. Friedlander,et al.  Role of dialysis modality in responses of blood monocytes and peritoneal macrophages to endotoxin stimulation. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  J. Westwick,et al.  Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha. , 1993, The American journal of pathology.

[8]  R. Beelen,et al.  Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study. , 1993, Kidney international.

[9]  W. Luttmann,et al.  Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-1β and TNFα , 1993 .

[10]  L. Aarden,et al.  Interleukin-6: its role in the cytokine network , 1992 .

[11]  E. Köttgen,et al.  Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle. , 1992, American journal of nephrology.

[12]  J. Briggs,et al.  Expression of transferrin receptors by monocytes and peritoneal macrophages from renal failure patients treated by continuous ambulatory peritoneal dialysis (CAPD) , 1991, European journal of clinical investigation.

[13]  M. Horwitz,et al.  Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium. , 1991, Journal of immunology.

[14]  C. Scheibenbogen,et al.  Developmental Regulation of the Cytokine Repertoire in Human Macrophages: IL‐1, IL‐6, TNF‐α, and M‐CSF , 1991, Journal of leukocyte biology.

[15]  S. Lewis,et al.  Host Defense Mechanisms in the Peritoneal Cavity of Continuous Ambulatory Peritoneal Dialysis Patients: First of Two Parts , 1991 .

[16]  A. Hartmann,et al.  Regulation of TNF-alpha, IL-1 and IL-6 synthesis in differentiating human monoblastoid leukemic U937 cells. , 1991, Leukemia research.

[17]  K. Nilsson,et al.  In vitro maturation of mononuclear phagocytes and susceptibility to HIV-1 infection. , 1991, Journal of acquired immune deficiency syndromes.

[18]  S. Lewis,et al.  Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. 2. Humoral defenses. , 1991, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[19]  E. Köttgen,et al.  Leukotriene B4 and tumor necrosis factor release from leukocytes: effect of peritoneal dialysate. , 1991, Nephron.

[20]  N. Topley,et al.  Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  J. Waniewski,et al.  Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. , 1990, Kidney international.

[22]  J. Briggs,et al.  Release of hydrogen peroxide and expression of HLA-DR and transferrin receptors by monocytes and peritoneal macrophages from patients undergoing continuous ambulatory peritoneal dialysis and normal controls. , 1990, Clinical immunology and immunopathology.

[23]  M R Loken,et al.  Quantitative Comparison of Myeloid Antigens on Five Lineages of Mature Peripheral Blood Cells , 1990, Journal of leukocyte biology.

[24]  I. Bonta,et al.  Endotoxin‐stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin‐1βin vitro during infectious peritonitis , 1990, European journal of clinical investigation.

[25]  E. Stylianou,et al.  Isolation, culture and characterization of human peritoneal mesothelial cells. , 1990, Kidney international.

[26]  C. Dinarello,et al.  Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. , 1990, Blood.

[27]  J. Vilček,et al.  IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. , 1989, Journal of immunology.

[28]  S. Davies,et al.  Activation of immunocompetent cells in the peritoneum of patients treated with CAPD. , 1989, Kidney international.

[29]  H. J. Bos,et al.  Peritoneal dialysis fluid induces change of mononuclear phagocyte proportions. , 1989, Kidney international.

[30]  J. Briggs,et al.  Longitudinal Study of Peritoneal Defence Mechanisms in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) , 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[31]  J. Dobbie.  Morphology of the peritoneum in CAPD. , 1989, Blood purification.

[32]  M. Mineshima,et al.  Functional deterioration of the peritoneum: does it occur in the absence of peritonitis? , 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  J. Briggs,et al.  Bactericidal activity of peritoneal macrophages from continuous ambulatory dialysis patients. , 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  R. Crystal,et al.  Expression of the transferrin receptor gene during the process of mononuclear phagocyte maturation. , 1986, Journal of immunology.

[35]  L. Tyrey.  Reversal of the delta-9-tetrahydrocannabinol inhibitory effect on prolactin secretion by rostral deafferentation of the medial basal hypothalamus. , 1986, Neuroendocrinology.

[36]  N. Di Paolo,et al.  Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. , 1986, Nephron.

[37]  G. Coles.  Is peritoneal dialysis a good long term treatment? , 1985, British medical journal.

[38]  P. Schollmeyer,et al.  Stimulation of peritoneal synthesis of vasoactive prostaglandins during peritonitis in patients on continuous ambulatory peritoneal dialysis , 1985, European journal of clinical investigation.

[39]  N. Hogg,et al.  Monoclonal antibodies specific for human monocytes, granulocytes and endothelium. , 1984, Immunology.

[40]  E. Neilson,et al.  Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. , 1984, Kidney international.

[41]  J. Weiel,et al.  Expression of the transferrin receptor in murine peritoneal macrophages is modulated in the different stages of activation. , 1984, Journal of immunology.

[42]  B. Faller,et al.  Loss of Ultrafil Tration in Continuous Ambulatory Peritoneal Dialysis: A Role for Acetate , 1984 .

[43]  T. Hamilton,et al.  The cell biology of macrophage activation. , 1984, Annual review of immunology.

[44]  B. Canaud,et al.  Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study. , 1983, Nephron.

[45]  L. Mcgann,et al.  Monoclonal antibodies against human granulocytes and myeloid differentiation antigens. , 1982, Human immunology.

[46]  M. Claeys,et al.  Arachidonic acid metabolism by cultured mesothelial cells: Different transformations of exogenously added and endogenously released substrate , 1982 .